Microarray analysis has garnered many accolades from the medical field due to the inherent advantages associated with it such as faster diagnosis, flexibility, economic benefits, accuracy, and others. Rising occurrence of genetic disorders has augmented the demand for advanced diagnosis screening methods which is aiding the growth of the global microarray analysis market. This coupled with raising concerns and initiatives from the governments in multiple countries have boosted the growth of the market. Government endeavors towards the modernization of healthcare sector in different countries coupled with the launch of various screening programs by governments favor the market growth. For instance, compulsory screening of newborns under the affordable healthcare act in the US acts as a plus for the growth of the market.